Status:
UNKNOWN
Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars
Lead Sponsor:
Alexandria University
Conditions:
Hypertrophic Scarring
Eligibility:
All Genders
18-40 years
Phase:
PHASE2
PHASE3
Brief Summary
Background: Scars widen when the overlying musculature pulls apart suture lines. Because Botulinum Toxin A (BTA) is known to prevent fibroblast proliferation and it also induces temporary muscle paral...
Detailed Description
1. All procedures were performed under local anesthesia in Oral and Maxillofacial Surgery Department, Alexandria University. 2. Using nonalcoholic solution after makeup removal, a single surgeon perfo...
Eligibility Criteria
Inclusion
- • Patients aged from 18 to 40 years.
- Patients free from any systemic disease.
- Patients who understand verbal and written instructions
Exclusion
- • Patients with horizontal forehead lacerations.
- Patients suffering from complicated forehead lacerations that require grafting.
- Patients with forehead burns.
- Patients with neuromuscular disorders.
- Patients with previous surgical or non-surgical intervention.
- Patients allergic to drugs used in this study
Key Trial Info
Start Date :
November 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04756882
Start Date
November 18 2020
End Date
September 1 2021
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
oral & maxillofacial surgery department ,faculty of dentistry, Alexandria university
Alexandria, Azarita, Egypt, 21500